Table 1.
Description | |
---|---|
Stage 1 | Duration of symptoms 0–3 months |
Pain with active and passive ROM | |
Limitation of forward flexion, abduction, internal rotation, external rotation | |
EUA: normal or minimal loss of ROM | |
Arthroscopy: diffuse glenohumeral synovitis | |
Pathology: hypertrophic, hypervascular synovitis; rare inflammatory cell infiltrates, normal capsule | |
Stage 2 | Duration of symptoms 3 to 9 months |
Chronic pain with active and passive ROM | |
Significant limitation of forward flexion, abduction, internal rotation, external rotation | |
EUA: no change in ROM compared with when patient is awake | |
Arthroscopy: diffuse, pedunculated synovitis | |
Pathology: hypertrophic, hypervascular synovitis with perivascular and subsynovial scar, fibroplasias, and scar formation in the underlying capsule | |
Stage 3 | Duration of symptoms 9 to 15 months |
Minimal pain except at end ROM | |
Significant limitation of ROM with rigid “end feel” | |
EUA: no change in ROM compared with when patient is awake | |
Arthroscopy: no hypervascularity seen; remnants of fibrotic synovium. Diminished capsular volume | |
Pathology: “burned out” synovitis without significant hypertrophy or hypervascularity. Dense scar formation of the capsule | |
Stage 4 | Duration of symptoms: 15 to 24 months |
Minimal pain | |
Progressive improvement in ROM |
ROM Range of motion, EUA examination under anesthesia